首页> 外文期刊>BJU international >Added value of diffusion‐weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial
【24h】

Added value of diffusion‐weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial

机译:多射磁共振成像中的扩散加权图像和动态对比度增强的增加,以检测临床显着的前列腺癌图片试验

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To determine the additional diagnostic value of diffusion‐weighted imaging (DWI) and dynamic contrast‐enhanced imaging (DCE) in men requiring a repeat biopsy within the PICTURE study. Patients and Methods PICTURE was a paired‐cohort confirmatory study in which 249 men who required further risk stratification after a previous non‐magnetic resonance imaging (MRI)‐guided transrectal ultrasonography‐guided biopsy underwent a 3‐Tesla (3T) multiparametic (mp)MRI consisting of T2‐weighted imaging (T2W), DWI and DCE, followed by transperineal template prostate mapping biopsy. Each mpMRI was reported using a LIKERT score in a sequential blinded manner to generate scores for T2W, T2W+DWI and T2W+DWI+DCE. Area under the receiver‐operating characteristic curve (AUROC) analysis was performed to compare the diagnostic accuracy of each combination. The threshold for a positive mpMRI was set at a LIKERT score ≥3. Clinically significant prostate cancer was analysed across a range of definitions including UCL/Ahmed definition 1 (primary definition), UCL/Ahmed definition 2, any Gleason ≥3 + 4 and any Gleason ≥4 + 3. Results Of 249 men, sequential MRI reporting was available for 246. There was a higher rate of equivocal lesions (44.6%) using T2W alone compared to the addition of DWI (23.9%) and DCE (19.8%). Using the primary definition of clinically significant disease, there was no significant difference in the overall accuracy between T2W, with an AUROC of 0.74 (95% confidence interval [CI] 0.68–0.80), T2W+DWI at 0.76 (95% CI 0.71–0.82), and T2W+DWI+DCE, with an AUROC of 0.77 (95% CI 0.71–0.82; P = 0.55). The AUROC values remained comparable using other definitions of clinically significant disease including UCL/Ahmed definition 2 ( P = 0.79), Gleason ≥3 + 4 ( P = 0.53) and Gleason ≥4 + 3 ( P = 0.53). Conclusions Using 3T MRI, a high level of diagnostic accuracy can be achieved using T2W as a single parameter in men with a prior biopsy; however, such a strategy can lead to a higher rate of equivocal lesions.
机译:目的确定在图像研究中需要重复活检的男性中扩散加权成像(DWI)和动态对比增强成像(DCE)的额外诊断值。患者和方法图片是一种配对 - 队列的核查研究,其中在先前的非磁共振成像(MRI) - 导委acrageRectal超声引导的活检后,249名需要进一步的风险分层进行进一步的风险分层,接受了3-Tesla(3T)多丙基(MP) MRI由T2加权成像(T2W),DWI和DCE组成,其次是经细胞内模板前列腺映射活检。报告每个MPMRI以顺序盲化方式使用李克特分数来生成T2W,T2W + DWI和T2W + DWI + DCE的分数。进行接收器操作特征曲线(Auroc)分析下的区域以比较每个组合的诊断准确性。正MPMRI的阈值设置为李克特分数≥3。分析了临床显着的前列腺癌,包括UCL / AHMED定义1(主要定义),UCL / AHMED定义2,任何GLEAN≥3+ 4以及任何GLEASON≥4+ 3.结果249人,顺序MRI报告的结果与添加DWI(23.9%)和DCE(19.8%),单独使用T2W,使用T2W的较高速度(44.6%)较高的较高速度(44.6%)。使用临床显着疾病的主要定义,T2W之间的整体精度没有显着差异,氧化氢氧化氢氧化氢菌率为0.74(95%置信区间[CI] 0.68-0.80),T2W + DWI 0.76(95%CI 0.71- 0.82)和T2W + DWI + DCE,Auroc为0.77(95%CI 0.71-0.82; P = 0.55)。使用UCL / Ahmed定义2(P = 0.79)的临床显着疾病的其他定义,Auroc值仍然可比,Gleason≥3+ 4(p = 0.53)和玻术≥4+ 3(p = 0.53)。结论使用3T MRI,可以使用T2W作为具有现有活检的男性的单个参数来实现高水平的诊断准确度;然而,这种策略可以导致较高的均衡病变率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号